Surgical site infection (SSI) occurs in up to 5% of patients following an inpatient surgical procedure, increasing average hospital length of stay by 9.7 days, risk of mortality by 2- to 11-fold, and costs of hospitalization by more than $20 000 per admission.1 SSIs are defined as either superficial (confined to the skin or subcutaneous tissue), deep (involving the muscle or fascia layers), or organ-space (involving the internal anatomic region where the operation was performed). Because more than half of SSIs are estimated to be preventable with evidence-based guidelines, SSI has been identified as an important quality indicator and is now a pay-for-performance metric.1-3
Fields AC, Pradarelli JC, Itani KMF. Preventing Surgical Site Infections: Looking Beyond the Current Guidelines. JAMA. 2020;323(11):1087–1088. doi:10.1001/jama.2019.20830
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: